Progyny, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Progyny, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q2 2024.
  • Progyny, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.38M, a 121% increase year-over-year.
  • Progyny, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $13.6M, a 207% increase year-over-year.
  • Progyny, Inc. annual Nonoperating Income (Expense) for 2023 was $8.51M, a 673% increase from 2022.
  • Progyny, Inc. annual Nonoperating Income (Expense) for 2022 was $1.1M, a 1058% increase from 2021.
  • Progyny, Inc. annual Nonoperating Income (Expense) for 2021 was $95K, a 71.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $13.6M $4.38M +$2.4M +121% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $11.2M $3.99M +$2.67M +202% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $8.51M $2.46M +$1.63M +195% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $6.88M $2.74M +$2.46M +865% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-29
Q2 2023 $4.42M $1.98M +$1.92M +2951% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.5M $1.32M +$1.4M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.1M $835K +$1.05M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $55K $284K +$232K +446% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-29
Q2 2022 -$177K $65K -$199K -75.4% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-29
Q1 2022 $22K -$84K -$73K -664% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-29
Q4 2021 $95K -$210K -$225K -1500% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $320K $52K +$58K Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 $262K $264K +$256K +3200% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 $6K -$11K -$325K -104% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 $331K $15K +$5.64M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$5.31M -$6K +$11.2M +99.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-01
Q2 2020 -$16.6M $8K +$778K Apr 1, 2020 Jun 30, 2020 10-K 2022-03-01
Q1 2020 -$17.3M $314K +$903K Jan 1, 2020 Mar 31, 2020 10-K 2022-03-01
Q4 2019 -$18.2M -$5.62M -$4.2M -296% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$14M -$11.3M -$10.3M -1091% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$3.73M -$770K +$33K +4.11% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$3.76M -$589K -$317K -117% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$3.44M -$1.42M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$945K Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$803K Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$272K Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.